De Renzo A - Search Results

1

Multiple myeloma cured by conventional chemotherapy: a report and a review.

Notaro R, De Renzo A, De Rosa G, Karadimitris A, Rotoli B. Notaro R, et al. Among authors: de rosa g, de renzo a. Leuk Lymphoma. 2002 Apr;43(4):907-10. doi: 10.1080/10428190290017097. Leuk Lymphoma. 2002. PMID: 12153185 Review.

2

Etoposide and idarubicin in a modified CHOP-like regimen (VICED) for aggressive non-Hodgkin's lymphomas.

De Renzo A, Notaro R, Pezzullo L, D'Arco A, Pagnini D, Pettinato G, Rotoli B. De Renzo A, et al. Leuk Lymphoma. 1998 Jun;30(1-2):153-62. doi: 10.3109/10428199809050938. Leuk Lymphoma. 1998. PMID: 9669685 Clinical Trial.

3

Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma.

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M. Fonti R, et al. Among authors: de renzo a. Cancer Biother Radiopharm. 2004 Apr;19(2):165-70. doi: 10.1089/108497804323071931. Cancer Biother Radiopharm. 2004. PMID: 15186596 Clinical Trial.

4

Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans.

Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B. Picardi M, et al. Among authors: de renzo a. Leuk Lymphoma. 2007 Sep;48(9):1721-7. doi: 10.1080/10428190701559140. Leuk Lymphoma. 2007. PMID: 17786707 Clinical Trial.

5

Different patterns of technetium-99m sestamibi uptake in multiple myeloma.

Pace L, Catalano L, Pinto A, De Renzo A, Di Gennaro F, Califano C, Del Vecchio S, Rotoli B, Salvatore M. Pace L, et al. Among authors: de renzo a. Eur J Nucl Med. 1998 Jul;25(7):714-20. doi: 10.1007/s002590050274. Eur J Nucl Med. 1998. PMID: 9662593 Clinical Trial.

6

Tc-99m sestamibi scintigraphy in multiple myeloma.

Di Gennaro F, Catalano L, Pace L, de Renzo A, Pinto AM, del Vecchio S, Rotoli B, Salvatore M. Di Gennaro F, et al. Among authors: de renzo a. Clin Nucl Med. 1999 Feb;24(2):115-6. doi: 10.1097/00003072-199902000-00009. Clin Nucl Med. 1999. PMID: 9988070

7

Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.

Catalano L, Pace L, Califano C, Pinto AM, De Renzo A, Di Gennaro F, Del Vecchio S, Fonti R, Salvatore M, Rotoli B. Catalano L, et al. Among authors: de renzo a. Haematologica. 1999 Feb;84(2):119-24. Haematologica. 1999. PMID: 10091409 Clinical Trial.

8

Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II.

De Renzo A, Santoro LF, Notaro R, Pane F, Buonaiuto MR, Luciano L, Rotoli B. De Renzo A, et al. Am J Hematol. 1999 Apr;60(4):300-4. doi: 10.1002/(sici)1096-8652(199904)60:4<300::aid-ajh8>3.0.co;2-o. Am J Hematol. 1999. PMID: 10203104 Free article.

9

Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M. Fonti R, et al. Among authors: de renzo a. Eur J Nucl Med. 2001 Feb;28(2):214-20. doi: 10.1007/s002590000434. Eur J Nucl Med. 2001. PMID: 11303893 Clinical Trial.

10

Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.

Pace L, Catalano L, Del Vecchio S, Di Gennaro F, De Renzo A, Sica G, Califano C, Tedesco N, Borrelli G, Rotoli B, Salvatore M. Pace L, et al. Among authors: de renzo a. Eur J Nucl Med. 2001 Mar;28(3):304-12. doi: 10.1007/s002590000440. Eur J Nucl Med. 2001. PMID: 11315597 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page